XML 99 R86.htm IDEA: XBRL DOCUMENT v3.25.3
Equity - Narrative (Details)
1 Months Ended 12 Months Ended
Jul. 23, 2024
$ / shares
Jul. 03, 2024
Jul. 02, 2024
Jun. 17, 2024
Jun. 16, 2024
Apr. 26, 2024
$ / shares
Apr. 10, 2024
Apr. 09, 2024
Mar. 26, 2024
$ / shares
shares
Jan. 22, 2024
USD ($)
D
$ / shares
shares
Apr. 01, 2022
shares
Mar. 31, 2023
USD ($)
shares
Dec. 31, 2024
USD ($)
vote
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
Jul. 22, 2024
$ / shares
Apr. 25, 2024
$ / shares
Jan. 25, 2024
USD ($)
Accumulated Other Comprehensive Income (Loss)                                    
Common stock authorized (in shares)                         950,000,000 950,000,000        
Common stock, par value (in dollars per share) | $ / shares                         $ 0.001 $ 0.001        
Number of votes entitled to each common stock holders | vote                         1          
Strike price (in dollars per share) | $ / shares $ 5.34         $ 0.68                   $ 6.80 $ 2.25  
Warrant duration                         5 years          
Gross proceeds | $                   $ 9,200,000                
Offering expenses | $                   800,000                
Warrant liability related to common stock issuance | $                   7,700,000     $ (7,661,557) $ 0 $ 0      
Stock Issued During Period, Value, New Issues | $                   $ 1,500,000     1,540,943 $ 1,900,000        
Warrant liability | $                                   $ 7,700,000
Weighted average prices                   100.00%                
Trading days | D                   10,000                
Conversion ratio 100 0.100 0.100 0.100 0 67.000 0.067 0.067                    
Warrants exercised (in shares)                           9,710        
Proceeds for exercised warrants | $                         2,373,336 $ 0 4,119,141      
Stock-based compensation | $                         $ 16,554,898 $ 2,835,971 $ 189,581      
Warrants issued (in shares)                           71,714        
Yorkville                                    
Accumulated Other Comprehensive Income (Loss)                                    
Common stock issued for acquisition (in shares)                           142,348        
Common Stock                                    
Accumulated Other Comprehensive Income (Loss)                                    
Common stock issued (in shares)                         444,444 6,667        
Stock Issued During Period, Value, New Issues | $                         $ 444 $ 7        
Common stock issued for acquisition (in shares)                     339,741   64,746 16,943        
Common Stock | Yorkville                                    
Accumulated Other Comprehensive Income (Loss)                                    
Common stock issued for acquisition (in shares)                         11,824          
Common Stock | Stock Purchase Agreement | Apollo Medical Holdings, Inc.                                    
Accumulated Other Comprehensive Income (Loss)                                    
Common stock issued (in shares)                       6,667            
Stock-based compensation | $                       $ 1,900,000            
PHA and MCIC                                    
Accumulated Other Comprehensive Income (Loss)                                    
Common stock issued for acquisition (in shares)                         64,746 16,943        
Prior to Reverse Stock Split                                    
Accumulated Other Comprehensive Income (Loss)                                    
Warrants issued to purchase of common stock (in shares)                         4,038,750          
Prior to Reverse Stock Split | Yorkville                                    
Accumulated Other Comprehensive Income (Loss)                                    
Common stock issued for acquisition (in shares)                         1,773,645 21,357,603        
Prior to Reverse Stock Split | Common Stock                                    
Accumulated Other Comprehensive Income (Loss)                                    
Common stock issued for acquisition (in shares)                     50,961,109              
Prior to Reverse Stock Split | Common Stock | Stock Purchase Agreement | Apollo Medical Holdings, Inc.                                    
Accumulated Other Comprehensive Income (Loss)                                    
Common stock issued (in shares)                       1,000,000            
Prior to Reverse Stock Split | PHA and MCIC                                    
Accumulated Other Comprehensive Income (Loss)                                    
Common stock issued for acquisition (in shares)                           2,541,511        
Volatility | Level 3                                    
Accumulated Other Comprehensive Income (Loss)                                    
Fair value of the warrant                   120                
Common Stock Warrants                                    
Accumulated Other Comprehensive Income (Loss)                                    
Warrants issued to purchase of common stock (in shares)                 89,750                  
Strike price (in dollars per share) | $ / shares                 $ 30.00                  
Warrant duration                         3 years 8 months 4 days 4 years 5 months 1 day 3 years 9 months 18 days      
Warrants exercised (in shares)                         444,445 9,710        
Warrants issued (in shares)                         444,445 71,714        
Warrants amended (in shares)                 71,801       71,801          
Common Stock Warrants | September 2023 Private Offering                                    
Accumulated Other Comprehensive Income (Loss)                                    
Strike price (in dollars per share) | $ / shares                           $ 60.00        
Warrant duration                           6 years        
Warrants issued (in shares)                           71,714        
Common Stock Warrants | Prior to Reverse Stock Split                                    
Accumulated Other Comprehensive Income (Loss)                                    
Warrants amended (in shares)                 10,770,000                  
Common Stock Warrants | Prior to Reverse Stock Split | September 2023 Private Offering                                    
Accumulated Other Comprehensive Income (Loss)                                    
Strike price (in dollars per share) | $ / shares                           $ 0.40        
Warrants issued (in shares)                           10,770,000        
Securities purchase agreement                                    
Accumulated Other Comprehensive Income (Loss)                                    
Common stock issued (in shares)                   444,445                
Warrants issued to purchase of common stock (in shares)                   444,445                
Warrants issued ratio                   1                
Offering price (in dollars per share) | $ / shares                   $ 22.50                
Strike price (in dollars per share) | $ / shares                   $ 22.50                
Warrant duration                   5 years                
Percentage of beneficially owned by such holder                   4.99%                
Percentage of beneficially owned by the issuance of any warrants                   9.99%                
Securities purchase agreement | Prior to Reverse Stock Split                                    
Accumulated Other Comprehensive Income (Loss)                                    
Common stock issued (in shares)                   66,666,666                
Warrants issued to purchase of common stock (in shares)                   66,666,666                
Offering price (in dollars per share) | $ / shares                   $ 0.15                
Strike price (in dollars per share) | $ / shares                   $ 0.15                
Securities purchase agreement | Common Stock Warrants                                    
Accumulated Other Comprehensive Income (Loss)                                    
Common stock issued (in shares)                         444,445          
Offering price (in dollars per share) | $ / shares                         $ 22.50          
Warrants exercised (in shares)                         444,445          
Proceeds for exercised warrants | $                         $ 2,400,000          
Warrants and rights outstanding | $                         0          
Adjustment of Warrants | $                         $ 1,600,000          
Securities purchase agreement | Common Stock Warrants | Prior to Reverse Stock Split                                    
Accumulated Other Comprehensive Income (Loss)                                    
Common stock issued (in shares)                         66,666,666          
Offering price (in dollars per share) | $ / shares                         $ 0.15